Improving Transparency and Accuracy in Medicare Part D Spending Act

Actions

• 2019-03-01Referred to the Subcommittee on Health.
• 2019-01-28Referred to the Subcommittee on Health.
• 2019-01-25Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
• 2019-01-25Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
• 2019-01-25Introduced in House
• 2019-01-25Introduced in House

CRS Summary

As of 2019-01-25 (00)

Cosponsors (20)

• H. Griffith (R-VA)
• Earl Carter (R-GA)
• Cathy Rodgers (R-WA)
• Doug Collins (R-GA)
• Ron Estes (R-KS)
• Eric Crawford (R-AR)
• Vicente Gonzalez (D-TX)
• Roger Marshall (R-KS)
• Bradley Byrne (R-AL)
• Mo Brooks (R-AL)
• LLOYD DOGGETT (D-TX)
• John Joyce (R-PA)
• Martha Roby (R-AL)
• Robert Latta (R-OH)
• Rick Allen (R-GA)
• Chellie Pingree (D-ME)
• J. Hill (R-AR)
• Jared Golden (D-ME)
• John Sarbanes (D-MD)
• Jaime Herrera Beutler (R-WA)

Subjects

• Medicare
• Prescription drugs